Orthofix Medical (OFIX) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.55% |
| Dec 31, 2025 | 23.02% |
| Sep 30, 2025 | 26.44% |
| Jun 30, 2025 | 10.71% |
| Mar 31, 2025 | 9.47% |
| Dec 31, 2024 | 10.15% |
| Sep 30, 2024 | 7.01% |
| Jun 30, 2024 | 14.43% |
| Mar 31, 2024 | 18.43% |
| Dec 31, 2023 | 32.49% |
| Sep 30, 2023 | 41.88% |
| Jun 30, 2023 | 33.15% |
| Mar 31, 2023 | 32.29% |
| Dec 31, 2022 | 16.78% |
| Sep 30, 2022 | 3.08% |
| Jun 30, 2022 | 11.47% |
| Mar 31, 2022 | 7.45% |
| Dec 31, 2021 | 12.22% |
| Sep 30, 2021 | -5.41% |
| Jun 30, 2021 | 5.83% |
| Mar 31, 2021 | -6.42% |
| Dec 31, 2020 | -9.09% |
| Sep 30, 2020 | -16.36% |
| Jun 30, 2020 | -12.68% |
| Mar 31, 2020 | -3.32% |
| Dec 31, 2019 | -4.85% |
| Sep 30, 2019 | -4.40% |
| Jun 30, 2019 | 15.14% |
| Mar 31, 2019 | 4.70% |
| Dec 31, 2018 | -5.66% |
| Sep 30, 2018 | -10.44% |
| Jun 30, 2018 | -15.37% |
| Mar 31, 2018 | -14.03% |
| Dec 31, 2017 | -19.91% |
| Sep 30, 2017 | -4.05% |
| Jun 30, 2017 | -12.39% |
| Mar 31, 2017 | -10.20% |
| Dec 31, 2016 | -15.54% |
| Sep 30, 2016 | -10.68% |
| Jun 30, 2016 | -8.27% |
| Mar 31, 2016 | 1.86% |
| Dec 31, 2015 | -7.16% |
| Sep 30, 2015 | 7.72% |